0001104659-23-095014.txt : 20230824
0001104659-23-095014.hdr.sgml : 20230824
20230824214700
ACCESSION NUMBER: 0001104659-23-095014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230823
FILED AS OF DATE: 20230824
DATE AS OF CHANGE: 20230824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIZZARI JEAN-PIERRE
CENTRAL INDEX KEY: 0001630914
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 231203693
MAIL ADDRESS:
STREET 1: 235 LAUREL LN
CITY: HAVERFOLD
STATE: PA
ZIP: 19041
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
BUSINESS PHONE: 267-370-5219
MAIL ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
4
1
tm2324788-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-08-23
0
0001781983
Aprea Therapeutics, Inc.
APRE
0001630914
BIZZARI JEAN-PIERRE
3805 OLD EASTON ROAD
DOYLESTOWN
PA
18902
1
0
0
0
0
Stock Options (Right to Buy)
3.65
2023-08-23
4
A
0
12500
0.00
A
2033-08-23
Common Stock
12500
12500
D
These options shall vest in full on the two year anniversary of the grant date, subject to the reporting person's continued service on the Issuer's board of Directors through and including the applicable vesting date.
/s/ John Hamill, as Attorney-in-Fact
2023-08-24